{"id":8606,"date":"2023-09-13T18:02:27","date_gmt":"2023-09-13T18:02:27","guid":{"rendered":"https:\/\/www.rawoodfoundation.org\/?p=8606"},"modified":"2023-09-14T13:34:42","modified_gmt":"2023-09-14T13:34:42","slug":"meilleures-pratiques-pour-les-participants-aux-essais-cliniques","status":"publish","type":"post","link":"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/clinical-trial-participant-best-practices\/","title":{"rendered":"Meilleures pratiques pour les participants aux essais cliniques"},"content":{"rendered":"<h2 class=\"wp-block-heading\">En tant que participant, il est important de faire sa part pour pr\u00e9server l'int\u00e9grit\u00e9 de l'\u00e9tude.<\/h2>\n\n\n\n<p>Participer \u00e0 un essai clinique est une d\u00e9cision personnelle, et il y a certainement des bonnes pratiques \u00e0 prendre en compte, en particulier lorsqu'il s'agit de partager son exp\u00e9rience en ligne.<\/p>\n\n\n\n<p>Dans un essai clinique \"en double aveugle, contr\u00f4l\u00e9 par placebo\", ni les participants ni les chercheurs ne sont cens\u00e9s savoir s'ils re\u00e7oivent le vrai m\u00e9dicament test\u00e9 ou le placebo. Cela permet de minimiser les biais et de s'assurer que les r\u00e9sultats de l'essai sont aussi objectifs que possible. Une \"\u00e9tude en double aveugle, contr\u00f4l\u00e9e par placebo\" est consid\u00e9r\u00e9e comme \"l'\u00e9talon-or\" de la recherche clinique, et les r\u00e9sultats de ce type d'essai sont donc plus susceptibles d'\u00eatre pris au s\u00e9rieux par les m\u00e9decins qui d\u00e9cident en fin de compte de prescrire ou non un nouveau m\u00e9dicament \u00e0 leurs patients. S'identifier comme participant \u00e0 un essai en aveugle dans les m\u00e9dias sociaux peut compromettre l'int\u00e9grit\u00e9 de l'\u00e9tude. Il est g\u00e9n\u00e9ralement conseill\u00e9 de ne pas divulguer cette information, car elle pourrait fausser les r\u00e9sultats. En outre, il est important de suivre les lignes directrices et les protocoles fournis par les organisateurs de l'essai.<\/p>\n\n\n\n<p>Si un participant ressent le besoin de discuter de son exp\u00e9rience, il doit le faire en priv\u00e9 et d'une mani\u00e8re qui ne r\u00e9v\u00e8le pas ouvertement sa participation \u00e0 l'essai ni son affectation au traitement. Il n'est pas conseill\u00e9 de r\u00e9v\u00e9ler sa participation ou celle de son enfant dans des groupes et des forums de m\u00e9dias sociaux o\u00f9 l'identit\u00e9 de tous les participants n'est pas connue.<\/p>\n\n\n\n<p>En fin de compte, les participants doivent consulter les organisateurs de l'essai ou leurs prestataires de soins de sant\u00e9 s'ils ont des questions ou des inqui\u00e9tudes sur la mani\u00e8re de communiquer au sujet de leur participation \u00e0 un essai clinique.<\/p>\n\n\n\n<p><strong>L'importance des groupes placebo<\/strong><\/p>\n\n\n\n<p>Les groupes placebo sont comme un point de comparaison dans les essais cliniques, et ils sont vraiment importants pour plusieurs raisons. Tout d'abord, ils permettent de d\u00e9terminer si un nouveau traitement est r\u00e9ellement efficace. En comparant le comportement des personnes qui suivent le traitement \u00e0 celui des personnes qui pensent simplement le suivre, les chercheurs peuvent d\u00e9terminer si le traitement est r\u00e9ellement efficace ou si c'est simplement notre esprit qui nous fait nous sentir mieux.<\/p>\n\n\n\n<p>L'existence d'un groupe placebo permet \u00e9galement de s'assurer que les r\u00e9sultats sont exacts. Il permet d'exclure toute autre raison qui pourrait expliquer l'am\u00e9lioration d'une personne, comme le hasard ou le fait qu'elle croit vraiment \u00e0 l'efficacit\u00e9 du traitement. De cette mani\u00e8re, il est possible de d\u00e9terminer si les am\u00e9liorations constat\u00e9es sont dues au traitement lui-m\u00eame.<\/p>\n\n\n\n<p>En d'autres termes, les groupes placebo permettent de v\u00e9rifier si un nouveau traitement fait r\u00e9ellement la diff\u00e9rence ou s'il s'agit d'autre chose. Cela aide les m\u00e9decins \u00e0 prendre les meilleures d\u00e9cisions quant aux traitements \u00e0 utiliser pour les patients.<\/p>\n\n\n\n<p>En tant que participant \u00e0 un essai clinique, vous devez<\/p>\n\n\n\n<p><strong>Donner la priorit\u00e9 \u00e0 la protection de la vie priv\u00e9e et \u00e0 la confidentialit\u00e9 :<\/strong><strong><br><\/strong>Respecter la vie priv\u00e9e des autres participants et suivre les accords de confidentialit\u00e9 ou les directives fournies par les organisateurs de l'essai.<\/p>\n\n\n\n<p><strong>V\u00e9rifier avec les organisateurs du proc\u00e8s :<\/strong><strong><br><\/strong>Avant de partager en ligne des informations sur votre exp\u00e9rience de l'essai, v\u00e9rifiez aupr\u00e8s des organisateurs de l'essai que vous n'enfreignez pas les protocoles ou les accords de l'essai.<\/p>\n\n\n\n<p><strong>Partage d'informations g\u00e9n\u00e9rales ou sp\u00e9cifiques :<br><\/strong>Vous pouvez partager des informations g\u00e9n\u00e9rales sur l'importance des essais cliniques et sur le fait qu'un essai particulier pour une pathologie donn\u00e9e est en cours, ainsi que sur les b\u00e9n\u00e9fices potentiels pour la soci\u00e9t\u00e9 et les futurs patients, sans divulguer de d\u00e9tails sp\u00e9cifiques sur les participants.<\/p>\n\n\n\n<p><strong>\u00c9viter la divulgation d'informations sensibles :<\/strong><strong><br><\/strong>S'abstenir de communiquer des d\u00e9tails sp\u00e9cifiques sur le traitement de l'essai, les participants, la posologie ou toute information exclusive qui pourrait compromettre l'int\u00e9grit\u00e9 de l'\u00e9tude.<\/p>\n\n\n\n<p><strong>Maintenir l'objectivit\u00e9 et l'\u00e9quilibre :<\/strong><strong><br><\/strong>Lorsque vous partagez votre exp\u00e9rience avec d'autres personnes en priv\u00e9, essayez de rester objectif. Reconnaissez que votre exp\u00e9rience n'est peut-\u00eatre pas repr\u00e9sentative de celle de tout le monde et que les essais cliniques peuvent avoir des r\u00e9sultats diff\u00e9rents selon les personnes.<\/p>\n\n\n\n<p><strong>Comprendre le consentement \u00e9clair\u00e9 :<\/strong><strong><br><\/strong>Avant de participer \u00e0 un essai, discutez en d\u00e9tail et comprenez les risques et les avantages avec vos fournisseurs de soins de sant\u00e9.<\/p>\n\n\n\n<p><strong>\u00c9viter de donner des conseils m\u00e9dicaux :<br><\/strong>Ne donnez pas d'avis m\u00e9dical et ne faites pas de recommandations de traitement sur la base de votre exp\u00e9rience d'essai. Encouragez les autres \u00e0 consulter leurs prestataires de soins de sant\u00e9 pour obtenir des conseils personnalis\u00e9s.<\/p>\n\n\n\n<p><strong>Utiliser un langage responsable et des clauses de non-responsabilit\u00e9 :<\/strong><strong><br><\/strong>Indiquez clairement que vous partagez votre exp\u00e9rience personnelle et qu'elle peut ne pas s'appliquer \u00e0 d'autres personnes.<\/p>\n\n\n\n<p><strong>Signaler les probl\u00e8mes aux organisateurs du proc\u00e8s :<\/strong><strong><br><\/strong>Si vous rencontrez des probl\u00e8mes ou des inqui\u00e9tudes au cours de l'essai, signalez-les rapidement aux organisateurs de l'essai ou \u00e0 votre fournisseur de soins de sant\u00e9.<\/p>\n\n\n\n<p>N'oubliez pas que votre exp\u00e9rience peut \u00eatre utile pour sensibiliser le public aux essais cliniques, mais il est essentiel de le faire de mani\u00e8re responsable et \u00e9thique. Donnez toujours la priorit\u00e9 \u00e0 l'int\u00e9grit\u00e9 de l'essai et au bien-\u00eatre des autres participants.<\/p>\n\n\n\n<p>Pour des informations sur les essais cliniques en cours, <a href=\"https:\/\/www.rawoodfoundation.org\/fr\/essais-cliniques\/\">visitez notre outil de recherche d'essais cliniques.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>En tant que participant, il est important que vous fassiez votre part pour maintenir l'int\u00e9grit\u00e9 du ... <a title=\"Meilleures pratiques pour les participants aux essais cliniques\" class=\"read-more\" href=\"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/clinical-trial-participant-best-practices\/\" aria-label=\"En savoir plus sur les meilleures pratiques pour les participants aux essais cliniques\">Lire plus<\/a><\/p>","protected":false},"author":6,"featured_media":8609,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41,20],"tags":[],"class_list":["post-8606","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy","category-latest-research","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33","no-featured-image-padding"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Trial Participant Best Practices - Raymond A. Wood Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/meilleures-pratiques-pour-les-participants-aux-essais-cliniques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trial Participant Best Practices - Raymond A. Wood Foundation\" \/>\n<meta property=\"og:description\" content=\"As a Participant, it&#8217;s Important to Do Your Part to Maintain the Integrity of the ... Lire plus\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/meilleures-pratiques-pour-les-participants-aux-essais-cliniques\/\" \/>\n<meta property=\"og:site_name\" content=\"Raymond A. Wood Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rawoodfoundation\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-13T18:02:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-14T13:34:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"927\" \/>\n\t<meta property=\"og:image:height\" content=\"618\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"RAWF\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@rawoodfound\" \/>\n<meta name=\"twitter:site\" content=\"@rawoodfound\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RAWF\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/\"},\"author\":{\"name\":\"RAWF\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/person\\\/12e3ee04f1646efc9cbbc13eb127f3b4\"},\"headline\":\"Clinical Trial Participant Best Practices\",\"datePublished\":\"2023-09-13T18:02:27+00:00\",\"dateModified\":\"2023-09-14T13:34:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/\"},\"wordCount\":758,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/clinical-trial.jpg\",\"articleSection\":[\"Advocacy\",\"Latest Research\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/\",\"name\":\"Clinical Trial Participant Best Practices - Raymond A. Wood Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/clinical-trial.jpg\",\"datePublished\":\"2023-09-13T18:02:27+00:00\",\"dateModified\":\"2023-09-14T13:34:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/clinical-trial.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/clinical-trial.jpg\",\"width\":927,\"height\":618,\"caption\":\"Patient being screened for a trial\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2023\\\/09\\\/13\\\/clinical-trial-participant-best-practices\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Trial Participant Best Practices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#website\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\",\"name\":\"Raymond A. Wood Foundation\",\"description\":\"The mission of the RAWF is to provide quality of life support for childhood brain tumor survivors and their families.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\",\"name\":\"Raymond A. Wood Foundation\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Raymond-A-Wood-Foundation-logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Raymond-A-Wood-Foundation-logo.webp\",\"width\":470,\"height\":128,\"caption\":\"Raymond A. Wood Foundation\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rawoodfoundation\",\"https:\\\/\\\/x.com\\\/rawoodfound\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/person\\\/12e3ee04f1646efc9cbbc13eb127f3b4\",\"name\":\"RAWF\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/fr\\\/author\\\/rawf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meilleures pratiques pour les participants aux essais cliniques - Raymond A. Wood Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/meilleures-pratiques-pour-les-participants-aux-essais-cliniques\/","og_locale":"fr_FR","og_type":"article","og_title":"Clinical Trial Participant Best Practices - Raymond A. Wood Foundation","og_description":"As a Participant, it&#8217;s Important to Do Your Part to Maintain the Integrity of the ... Lire plus","og_url":"https:\/\/www.rawoodfoundation.org\/fr\/2023\/09\/13\/meilleures-pratiques-pour-les-participants-aux-essais-cliniques\/","og_site_name":"Raymond A. Wood Foundation","article_publisher":"https:\/\/www.facebook.com\/rawoodfoundation","article_published_time":"2023-09-13T18:02:27+00:00","article_modified_time":"2023-09-14T13:34:42+00:00","og_image":[{"width":927,"height":618,"url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg","type":"image\/jpeg"}],"author":"RAWF","twitter_card":"summary_large_image","twitter_creator":"@rawoodfound","twitter_site":"@rawoodfound","twitter_misc":{"Written by":"RAWF","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#article","isPartOf":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/"},"author":{"name":"RAWF","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/person\/12e3ee04f1646efc9cbbc13eb127f3b4"},"headline":"Clinical Trial Participant Best Practices","datePublished":"2023-09-13T18:02:27+00:00","dateModified":"2023-09-14T13:34:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/"},"wordCount":758,"publisher":{"@id":"https:\/\/www.rawoodfoundation.org\/#organization"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg","articleSection":["Advocacy","Latest Research"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/","url":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/","name":"Meilleures pratiques pour les participants aux essais cliniques - Raymond A. Wood Foundation","isPartOf":{"@id":"https:\/\/www.rawoodfoundation.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#primaryimage"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg","datePublished":"2023-09-13T18:02:27+00:00","dateModified":"2023-09-14T13:34:42+00:00","breadcrumb":{"@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#primaryimage","url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg","contentUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/09\/clinical-trial.jpg","width":927,"height":618,"caption":"Patient being screened for a trial"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rawoodfoundation.org\/2023\/09\/13\/clinical-trial-participant-best-practices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rawoodfoundation.org\/"},{"@type":"ListItem","position":2,"name":"Clinical Trial Participant Best Practices"}]},{"@type":"WebSite","@id":"https:\/\/www.rawoodfoundation.org\/#website","url":"https:\/\/www.rawoodfoundation.org\/","name":"Fondation Raymond A. Wood","description":"La mission de la RAWF est d'apporter un soutien \u00e0 la qualit\u00e9 de vie des survivants de tumeurs c\u00e9r\u00e9brales infantiles et de leurs familles.","publisher":{"@id":"https:\/\/www.rawoodfoundation.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rawoodfoundation.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.rawoodfoundation.org\/#organization","name":"Fondation Raymond A. Wood","url":"https:\/\/www.rawoodfoundation.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/07\/Raymond-A-Wood-Foundation-logo.webp","contentUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/07\/Raymond-A-Wood-Foundation-logo.webp","width":470,"height":128,"caption":"Raymond A. Wood Foundation"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rawoodfoundation","https:\/\/x.com\/rawoodfound"]},{"@type":"Person","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/person\/12e3ee04f1646efc9cbbc13eb127f3b4","name":"RAWF","url":"https:\/\/www.rawoodfoundation.org\/fr\/author\/rawf\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/posts\/8606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/comments?post=8606"}],"version-history":[{"count":4,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/posts\/8606\/revisions"}],"predecessor-version":[{"id":8614,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/posts\/8606\/revisions\/8614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/media\/8609"}],"wp:attachment":[{"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/media?parent=8606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/categories?post=8606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/fr\/wp-json\/wp\/v2\/tags?post=8606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}